What are the opening hours?

Monday 8am - 6pm Tuesday 8am - 6pm Wednesday 8am - 6pm Thursday 8am - 6pm Friday 8am - 6pm

Avance Biosciences Inc.

Name: Avance Biosciences Inc.
Address: 9770 W Little York Road, Houston, TX, 77040, US
Telephone: +18329688698
Price range: $$

Home
United States
Houston, TX
Avance Biosciences Inc.

Avance Biosciences is a leading CRO providing GLP/GMP-compliant assay development, assay validation,

Avance Biosciences is a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide. Our leading scientists have designed and completed hundreds of testing projects under cGMP/GLP regulations for the FDA, EPA, as well as European and Japanese regulatory agencies. This team ha

s extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world. When you partner with Avance Biosciences, we give you undivided attention, share our experience and knowledge, and respond to your needs in a timely manner. Contact our technical staff to discuss how we can support you in your project! For detailed information, please visit www.avancebio.com or send us an email at [email protected].

03/13/2025

Avance Biosciences is excited to join WRIB 2025 in New Orleans, showcasing our expertise in bioanalytical testing for biologics and biosimilars. Visit us at Booth #78 to explore our advanced solutions, including LBA, Flow Cytometry, qPCR, and LC-MS/MS.

Avance Biosciences is excited to announce its participation in the upcoming WRIB Conference, taking place from April 7 - 11, 2025, in New Orleans, LA. This premier event is focused advancing regulatory science, innovation, and best practices in biologics and biosimilars, bringing together experts to...

02/26/2025

A groundbreaking using rAAV8.hRKp.AIPL1 has restored vision in 11 children with AIPL1-related (LCA4), who were blind at birth. Published in The Lancet, the study shows significant improvements in visual acuity and retinal preservation, supporting expedited approval efforts for this life-changing treatment.

As disclosed in the paper, 4 out of 4 young children with the AIPL1-related retinal dystrophy, LCA4, benefited substantially from unilateral subretinal administration of rAAV8.hRKp.AIPL1 with improved visual acuity, functional vision, and protection against progressive retinal degeneration Following...

11/07/2024

Avance fully embraced Halloween last Thursday with a costume contest, candy galore, and a pizza party. The day was filled with fun, warmth, and cheer as everyone shared in the festive spirit and made lasting memories together.

Well, well, well... it was a TREAT — and a big one for a lucky few! Avance fully embraced Halloween last Thursday with a costume contest, candy galore, and a pizza party. The costume contest was a great way to bring everyone together, with employees voting for winners in five fun categories: Trend...

10/31/2024

Avance Biosciences is excited to announce its participation in the upcoming SITC Conference, taking place from November 6-10, 2024, in Houston TX. This premier event is focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied .

10/17/2024

Avance Biosciences will be exhibiting at the AAPS PharmSci 360 meeting from October 15-18, 2024. Join us to explore our innovative biological assay development and testing services that can help you navigate drug development challenges. See you there!

Avance Biosciences™, a globally recognized Contract Research Organization (CRO), is excited to announce our participation in the upcoming AAPS PharmSci 360 meeting, taking place from October 15-18, 2024. This premier event brings together industry professionals and academic leaders to discuss inno...

10/03/2024

Avance Biosciences is excited to announce its participation in the upcoming Immunogenicity & Bioassay Summit, taking place from October 15 -18, 2024, in Washington DC. This is the #1 Immunogenicity & Bioassay Event in the U.S.

09/13/2024

Our team will showcase our cutting-edge expertise in analysis, particularly focusing on on/off-target effects, which are crucial for the development of safe and effective -based therapies. Our comprehensive services, including GUIDE-Seq, rhAmpSeq™, and advanced amplicon sequencing, are designed to ensure the precision and reliability of gene editing technologies.

Avance Biosciences is excited to announce its participation in the upcoming 2nd CRISPR-Based Therapy Analytical Development Summit, taking place from September 17-19, 2024, in Boston, MA. This premier event is a key gathering for professionals and innovators in the gene editing and CRISPR fields. At...

09/03/2024

Avance Biosciences is heading to the 2nd CRISPR-Based Therapy Analytical Development Summit in Boston from September 17-19! Join us to explore our cutting-edge expertise in gene editing analysis, including GUIDE-Seq and rhAmpSeq™, and see how our innovative solutions ensure precise and reliable CRISPR therapies.

08/20/2024

The groundbreaking -based gene therapy, exagamglogene autotemcel (exa-cel), will soon be available for those with severe beta-thalassaemia. This one-time treatment could potentially end the need for regular blood transfusions and marks a significant advancement in for this condition.

Patients in England with severe beta-thalassaemia will be amongst the first in Europe to benefit from one-time gene therapy exagamglogene autotemcel. NICE’s final draft guidance recommends exagamglogene autotemcel (“exa-cel”, also called Casgevy and made by Vertex) for people 12 years and over...

08/06/2024

“The approval of this state-of-the-art technology provides a critical new option for a patient population in need and demonstrates the FDA’s dedication to the advancement of beneficial .” - U.S. Food and Drug Administration Center for Biologics Evaluation and Research (CBER)

The U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA antigen(s) A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and...

07/31/2024

Two hallmark toxicities of chimeric antigen receptor (CAR) T-cell therapy may be rare after 2 weeks following infusion in patients with diffuse large B-cell lymphoma (DLBCL), supporting a shorter, more flexible toxicity monitoring period.

Two hallmark toxicities of chimeric antigen receptor (CAR) T-cell therapy may be rare after 2 weeks following infusion

07/15/2024

Avance Biosciences is excited to announce that our newly designed website is now live! Our new site features a clear and simplistic design, making it easy for current and potential customers to navigate and discover our comprehensive offerings for assay development, validation, and sample testing in compliance with FDA regulations.

Visit us at www.avancebio.com.

We greatly appreciate our marketing team's exceptional work on this project, completing the new website in just a couple of months. Even more so, we are incredibly proud of our laboratory and quality teams, along with all supporting crew, who over the past 14 years have built an impressive array of analytical and bioanalytical tools to support drug development and manufacturing activities!

Analytical and Bioanalytical Solutions Empowering Drug Development and Manufacturing Welcome to Avance Biosciences Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant

Address

9770 W Little York Road
Houston, TX
77040

Opening Hours

Monday	8am - 6pm
Tuesday	8am - 6pm
Wednesday	8am - 6pm
Thursday	8am - 6pm
Friday	8am - 6pm

Telephone

+18329688698

Website

https://www.avancebio.com/

Alerts

Be the first to know and let us send you an email when Avance Biosciences Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Avance Biosciences Inc.:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Business
Claim ownership or report listing

Want your business to be the top-listed Business in Houston?

Our Story

Our leading scientists have designed and completed hundreds of testing projects under cGMP/GLP regulations for the FDA, EPA, as well as European and Japanese regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.

When you partner with Avance Biosciences, we give you undivided attention, share our experience and knowledge, and respond to your needs in a timely manner. Contact our technical staff to discuss how we can support you in your project! For detailed information, please visit www.avancebio.com or send us an email at [email protected].